The UK’s National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) have published a new jointly developed guideline on antimicrobial prescribing for Clostridioides difficile (C. difficile) infection.
One in 10 hospital patients who develop Clostridioides difficile infections may already have the dangerous germ when admitted, but no diarrhea symptoms, a new study finds.